Abstract
An overview of alcohol metabolism is presented followed by a discussion of the unique pathways for the metabolism of ethanol by the heart. The evidence for cardiac metabolic injury produced as a result of ethanol metabolism is then presented. Such injury involves the mitochondria, contractile proteins, and alterations in calcium fluxes and storage.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Van Thiel DH: Effects of ethanol upon organ systems other than the central nervous system, in Tabakoff B, Sutker PB, Randall CL (eds): Medical and Social Aspects of Alcohol Abuse. New York, Plenum Press, 1983, pp 95–97.
Alcohol and Health Third Special Report to the U.S. Congress for the Secretary of Health, Education, and Welfare, USPO Stock #017-024-00892-3, June 1978, pp 109–119.
Brigden W, Robinson J: Alcoholic heart disease. Br Med J 2:1283–1289, 1964.
Alexander CS: Electron microscopic observations in alcoholic heart disease. Br Heart J 29:200–206, 1967.
Alderman EL, Coltart DJ: Alcohol and the heart. Br Med Bull 38:77–90, 1982.
Schwartz L, Sample KA, Wigle ED: Severe alcoholic cardiomyopathy reversed with abstention from alcohol. Am J Cardiol 36:963–966, 1975.
Smith M, Hopkinson DA, Harris H: Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 34:251–271, 1971.
Smith M, Hopkinson DA, Harris H: Studies on the subunit structure and molecular size of the human alcohol dehydrogenase isozymes determined by the different loci ADH1 ADH2 and ADH3. Ann Hum Genet 36:401–414, 1973.
Stanatoamnopoulous G, Chen S, Fukui M: Liver alcohol dehydrogenase in Japanese: High population frequency of atypical forms and its possible role in alcohol sensitivity. Am J Hum Genet 27:789–796, 1975.
Lieber CS: Metabolism of Alcohol in Medical Disorders of Alcoholism Pathogenesis and Treatment. Philadelphia, WB Saunders, 1982, pp 1–42.
Lochner A, Cowley R, Brink AJ: Effect of ethanol on metabolism and function of perfused rat heart. Am Heart J 78:770–780, 1969.
Segel LD, Rendig SV, Choquet Y, et al: Effects of chronic graded ethanol consumption in the metabolism ultrastructure and mechanical function of the rat heart. Cardiovasc Res 9:649–663, 1975.
Lange LG, Sobel BE: Mitochondrial dysfunction induced by fatty acid ethyl esters, myocardial metabolites of ethanol. J Clin Invest 72:724–731, 1983.
Bing RJ: Cardiac metabolism: Its contributions to alcoholic heart disease and myocardial failure. Circulation 58:965–970, 1978.
Lange LG, Bergmann SR, Sobel BE: Identification of fatty acid ethyl esters as products of rabbit myocardial ethanol metabolism. J Biol Chem 256:12968–12972, 1981.
Williams SS, Li TK: The effect of chronic alcohol administration on fatty acid metabolism and pyruvate oxidation of heart mitochondria. J Mol Cell Cardiol 12:1003–1011, 1977.
Pachinger OM, Tillmanns H, Mao JC, et al: The effect of prolonged administration of ethanol on cardiac metabolism and performance in the dog. J Clin Invest 52:2690–2696, 1973.
Kikuchi T, Kako KJ: Metabolic effects of ethanol on the rabbit heart. Circ Res 26:625–634, 1970.
Wendt VE, Wu C, Balcon R, et al: Hemodynamic and metabolic effects of chronic alcoholism in man. Am J Cardiol 25:175–184, 1965.
Segel LD, Rendig SV, Mason DT: Left ventricular dysfunction of isolated working rat hearts after chronic alcohol consumption. Cardiovasc Res 13:136–146, 1979.
Bing RJ, Tillmanns H, Fauvel JM, et al: Effect of prolonged alcohol administration on calcium transport in heart muscle of the dog. Circ Res 35:33–38, 1974.
Schreiber SS, Briden J, Oratz M, et al: Ethanol acetaldehyde and myocardial protein synthesis. J Clin Invest 51:2820–2826, 1972.
Schreiber S.S., Oratz M., Rothschild M.A., et al: Alcoholic cardiomyopathy II. J Mol Cell Cardiol 6:207–213, 1974.
Zuhlke V, du Mesnil de Rochemont W, Gudbjarnason S, et al: Inhibition of protein synthesis in cardiac hypertrophy and its relation to myocardial failure. Circ Res 18:558–572, 1966.
Fassold, E, Nayler WG, Kukovetz WR: Inhibition of cardiac Ca++ dependent myofibrillar ATPase by acetaldehyde. Nannyn-Schmiedeberg’s Arch of Pathology 302:R33–37, 1978.
Schwartz A, Sordahl LA, Entman ML, et al: Abnormal biochemistry in myocardial failure. Am J Cardiol 32:407–122, 1973.
Sulakhe R. V., Dhalla N.S.: Excitation contraction coupling in heart. J Clin Invest 50:1019–1027, 1971.
Goodman DS, Deykin D: Fatty acid ethyl ester formation during ethanol metabolism in vivo. Proc Soc Exp Biol Med 113:65–67, 1963.
Lange LG: Nonoxidative ethanol metabolism: Formation of fatty acid ethyl esters by cholesterol esterase. Proc Natl Acad Sci USA 79:3954–3957, 1983.
Lange LG, Sobel BE: Myocardial metabolites of ethanol. Circ Res 52:479–482, 1983.
Schwartz A, Levey GS, Entman ML, et al: Modulation of calcium in the heart, in Kobayoshi T, Sano T, Dhalla NS (eds): Recent Advances in Studies of Cardiac Structure and Metabolism. Baltimore, University Park Press, 1978, pp 195–198.
Holroyde MJ, Howe E, Solaro RJ: Modification of calcium requirements for activation of cardiac myofibrillar ATPase by cyclic AMP-dependent phosphorylation. Biochem Biophys Acta 586:63–69, 1979.
Mope L, McClellan GB, Winegard S: Calcium sensitivity of the contractile system and phosphorylation of troponin in hyperpermeable cardiac cells. J Gen Physiol 75:271–282, 1980.
Kopp SJ, Barany M: Phosphorylation of the 19,000-dalton light chain of myosin in perfused rat heart under the influence of negative and positive inotopic agents. J Biol Chem 254:12007–12012, 1979.
LePeuch CJ, Haiech J, Démaille JG: Concerted regulation of cardiac sarcoplasmic reticulum calcium transport by cyclic adenosine monophosphate dependent and calcium-calmodulin-dependent phosphorylations. Biochemistry 18:5150–5157, 1979.
Kranias EG, Mandel F, Wang T, et al: Mechanism of the stimulation of calcium ion dependent adenosine triphosphatase of cardiac sarcoplasmic reticulum by adenosine 3′5′-monophos-pohate dependent protein kinase. Biochemistry 19:5434–5439, 1980.
Ohmori F, Tada M, Kinoshita N, et al: Effect of protein kinase modulator on cAMP-dependent protein kinase-catalyzed phosphorylation of phospholamban and stimulation of calcium transport in cardiac sarcoplasmic reticulum, in Kobayashi T., Sano T., Dhalla N.S. (eds): Recent Advances in Studies of Cardiac Structure and Metabolism. Baltimore, University Park Press, 1978, pp 279–284.
Tsien RW: Cyclic AMP and contractile activity in heart. Adv Cyclic Nucleotide Res 8:363–420, 1977.
Bilezikijian LM, Kranias EG, Potter JD, et al: Studies on phosphorylation of canine cardiac sarcoplasmic reticulum by calmodulin-dependent protein kinase. Circ Res 49:1356–1362, 1981.
Wolf H, Hofmann F: Purification of myosin light chain kinase from canine cardiac muscle. Proc Natl Acad Sei USA 77:5852–5855, 1980.
Scheuer J, Bahn AK: Cardiac contractile proteins: Adenosine triphosphatase activity and physiological function. Circ Res 45:1–12, 1979.
Wang T, Grasside Gende A.O., Schwartz A.: Kinetic properties of calcium adnenosine triphosphatase of seroplasmic reticulum isolated from cat skeletal muscles. J Biol Chem 254:10675–10678, 1979.
Swartz MH, Repke DI, Katz AM, et al: Effects of ethanol on calcium binding and calcium uptake by cardiac microsomes. Biochem Pharmacol 23:2369–2376, 1974.
Williams JW, Tada M, Katz AM, et al: Effect of ethanol and acetaldehyde on the (Na+ + K+)activated adenosine triphosphatase activity of cardiac plasma membranes. Biochem Pharmacol 24:27–52, 1975.
Weber AJ: On the role of calcium in the activity of adenosine 5′-triphosphate hydrolysis by actomyosin. J Biol Chem 234:2764–2769, 1959.
Puszkin S, Rubin E: Adenosine diphosphate effect on contractility of human muscle actomyosin: Inhibition by ethanol and acetaldehyde. Science 188:1319–1320, 1975.
Retig JN, Kirchberger MA, Rubin E, et al: Effects of ethanol on calcium transport by microsomes phosphorylated by cyclic AMP-dependent protein kinase. Biochem Pharmacol 26:393–396, 1977.
Vesely DL, Lehotay DC, Levey GS: Effects of ethanol on myocardial guamylate and adenylate cyclase activity and on cyclic cAMP and GMP levels. J Stud Alcohol 39:842–847, 1978.
Whetton AD, Needham L, Dodd NJF, et al: Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity. Biochem Pharmacol 32:1601–1608, 1983.
Polimeni PI, Otten MD, Hoeschen LE: In vivo effects of ethanol on the rat myocardium: Evidence for a reversible, non-specific increase of sarcolemmal permeability. J Mol Cell Cardiol 15:113–122, 1983.
Rottenberg H, Waring AJ, Rubin E: Tolerance and cross-tolerance in chronic alcoholics: Reduced membrane binding of ethanol and other drugs. Science 213:583–585, 1981.
Van Vleet JF, Hall BV, Simon J: Vitamin E deficiency. A sequential light and electron microscopic study of skeletal muscle degeneration in weaning rabbits. Am J Pathol 52:1067–1079, 1968.
Myers CE, McGuire W, Young R: Adinomyocin: Amelioration of toxicity by alpha-tocopherol. Cancer Treat Rep 60:961–962, 1976.
Kuo JF, Andersson GGA, Wise BC, et al: Calcium-dependent protein kinase: Widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin and trifluoperazine. Proc Natl Acad Sci USA 77:7039–7043, 1980.
Ogawa Y, Takai Y, Kawahara Y, et al: A new possible regulatory system for protein phosphorylation in human peripheral lymphocytes. J Immunol 127:1369–1375, 1981.
Kawahara Y, Takai Y, Minakuchi R, et al: Possible involvement of Ca2+-activated, phospho-lipid-dependent protein kinase in platelet activation. J Biochem 88:913–916, 1980.
Sano K, Takai Y, Yamaniski J, et al: A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. J Biol Chem 258:2010–2013, 1983.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Plenum Press, New York
About this chapter
Cite this chapter
Van Thiel, D.H., Gavaler, J.S., Lehotay, D.C. (1985). Biochemical Mechanisms Responsible for Alcohol-Associated Myocardiopathy. In: Galanter, M. (eds) Recent Developments in Alcoholism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7715-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7715-7_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7717-1
Online ISBN: 978-1-4615-7715-7
eBook Packages: Springer Book Archive